i can't understand the announcement
it states: "transaction related to the grant of a perpetual licence...The effect of this is that $20.3 million of revenue will be reversed and reflected in the full year results."
yet i can't find recognition of this, what appears to be non-cash revenue, in the past accounts
i read in the past 3 sets of accounts $254M in revenue versus $269M in cash received from operations
if this $20,3M relates to "revenue" then the company is making a massive loss on his day-to-day trading operations
very difficult to follow
for 30/6/15, there was operating cash flow loss of $17.8
for 31/12/15, positive operating cash flow of $2.3
for the 6 months, inventory up $11M & payables up $16M
anyway..got to go now
- Forums
- ASX - By Stock
- SRF
- Ann: Company Update-SRF.AX
Ann: Company Update-SRF.AX, page-20
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRF (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online